Ryu, J., Rämö, J. T., Jurgens, S. J., Niiranen, T., Sanna-Cherchi, S., Bauer, K. A., Haj, A., Choi, S. H., Palotie, A., Daly, M., Ellinor, P. T., & Bendapudi, P. K. (2024). Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank. Blood, 143(23), 2425–2432. https://doi.org/10.1182/blood.2023023326

Nester, C., Decker, D. A., Meier, M., Aslam, S., Bomback, A. S., Caravaca-Fontán, F., Cook, T. H., Feldman, D. L., Fremeaux-Bacchi, V., Gale, D. P., Gooch, A., Johnson, S., Licht, C., Mathur, M., Pickering, M. C., Praga, M., Remuzzi, G., Selvarajah, V., Smith, R. J., … Thompson, A. (2024). Developing Therapies for C3 Glomerulopathy. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000000000000505

Arman, F., Crew, R. J., Stokes, M. B., & Radhakrishnan, J. (2024). Recurrent 2,8-Dihydroxyadenine Crystalline Nephropathy in Renal Allograft. Annals of Internal Medicine: Clinical Cases, 3(6). https://doi.org/10.7326/aimcc.2023.1255

Mohan, S., & Husain, S. A. (2024). Legislative and Regulatory Changes Affecting the US Transplant System. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000000000422

Krishna Murthy, S. B., Yang, S., Bheda, S., Tomar, N., Li, H., Yaghoobi, A., Khan, A., Kiryluk, K., Motelow, J. E., Ren, N., Gharavi, A. G., & Milo Rasouly, H. (2024). Assisting the analysis of insertions and deletions using regional allele frequencies. Functional & Integrative Genomics, 24(3). https://doi.org/10.1007/s10142-024-01358-3

Zhao, H., Petrey, D., Murray, D., & Honig, B. (2024). ZEPPI: Proteome-scale sequence-based evaluation of protein–protein interaction models. Proceedings of the National Academy of Sciences, 121(21). https://doi.org/10.1073/pnas.2400260121

Rosenberger, G., Li, W., Turunen, M., He, J., Subramaniam, P. S., Pampou, S., Griffin, A. T., Karan, C., Kerwin, P., Murray, D., Honig, B., Liu, Y., & Califano, A. (2024). Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47957-3

Vong, K. I., Lee, S., Au, K. S., Crowley, T. B., Capra, V., Martino, J., Haller, M., Araújo, C., Machado, H. R., George, R., Gerding, B., James, K. N., Stanley, V., Jiang, N., Alu, K., Meave, N., Nidhiry, A. S., Jiwani, F., Tang, I., … Gleeson, J. G. (2024). Risk of meningomyelocele mediated by the common 22q11.2 deletion. Science, 384(6695), 584–590. https://doi.org/10.1126/science.adl1624

Wooden, B., Nester, C. M., & Bomback, A. S. (2024). Update on C3 Glomerulopathy. Advances in Kidney Disease and Health, 31(3), 223–233. https://doi.org/10.1053/j.akdh.2024.05.002

Fakhouri, F., Bomback, A., Kavanagh, D., Remuzzi, G., Sunder-Plassmann, G., Kanellis, J., Daina, E., Walker, P., Wang, Z., & Ahmad, Z. (2024). #1467 Pegcetacoplan for post-transplant recurrent C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis in NOBLE: 12-week evolution. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.442

Zanoni, F., Naesens, M., Leal, R., Amoroso, A., Caliskan, Y., Keating, B., Gharavi, A., Castellano, G., Batal, I., & Kiryluk, K. (2024). #1450 Polygenic risk score of native IgA nephropathy predicts risk of post-transplant disease recurrence. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.184

Lewis, A. C. F., Chisholm, R. L., Connolly, J. J., Esplin, E. D., Glessner, J., Gordon, A., Green, R. C., Hakonarson, H., Harr, M., Holm, I. A., Jarvik, G. P., Karlson, E., Kenny, E. E., Kottyan, L., Lennon, N., Linder, J. E., Luo, Y., Martin, L. J., Perez, E., … Fullerton, S. M. (2024). Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network. The American Journal of Human Genetics, 111(6), 999–1005. https://doi.org/10.1016/j.ajhg.2024.04.005

Madden, E. B., Hindorff, L. A., Bonham, V. L., Akintobi, T. H., Burchard, E. G., Baker, K. E., Begay, R. L., Carpten, J. D., Cox, N. J., Di Francesco, V., Dillard, D. A., Fletcher, F. E., Fullerton, S. M., Garrison, N. A., Hammack-Aviran, C. M., Hiratsuka, V. Y., Hildreth, J. E. K., Horowitz, C. R., Hughes Halbert, C. A., … Green, E. D. (2024). Advancing genomics to improve health equity. Nature Genetics, 56(5), 752–757. https://doi.org/10.1038/s41588-024-01711-z

Mosley, J. D., Shelley, J. P., Dickson, A. L., Zanussi, J., Daniel, L. L., Zheng, N. S., Bastarache, L., Wei, W.-Q., Shi, M., Jarvik, G. P., Rosenthal, E. A., Khan, A., Sherafati, A., Kullo, I. J., Walunas, T. L., Glessner, J., Hakonarson, H., Cox, N. J., Roden, D. M., … Kawai, V. K. (2024). Clinical associations with a polygenic predisposition to benign lower white blood cell counts. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47804-5

Baugh, M., & Sabatello, M. (2024). Whether Whole Eye Transplant is a Benefit or Harm Depends on More Than the Observer. The American Journal of Bioethics, 24(5), 87–90. https://doi.org/10.1080/15265161.2024.2328281

Jørgensen, H. S., Moe, S., & Nickolas, T. L. (2024). Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease. Journal of Bone and Mineral Research, 39(5), 531–535. https://doi.org/10.1093/jbmr/zjae062

Kuker, A. P., Agarwal, S., Shane, E., Bicca, J., Geer, E. B., Cremers, S., Dworakowski, E., Cohen, A., Nickolas, T. L., Stein, E. M., & Freda, P. U. (2024). Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT. Journal of the Endocrine Society, 8(6). https://doi.org/10.1210/jendso/bvae079

Yu, M., King, K. L., Maclay, L. M., Husain, S. A., Schold, J. D., & Mohan, S. (2024). Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.04.006

Chang, J.-H., Kudose, S., Droubi, S., Verduzco, H. A., Awori, J., Ratner, L. E., & Mohan, S. (2024). Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney International Reports, 9(6), 1903–1907. https://doi.org/10.1016/j.ekir.2024.04.010

Yu, M., King, K. L., Husain, S. A., Schold, J. D., & Mohan, S. (2024). Use of Offer Bypass Filters under the Circular Kidney Allocation System. Kidney360, 5(5), 756–758. https://doi.org/10.34067/kid.0000000000000423

Escudero-Saiz, V. J., Gonzalez, Á., García-Herrera, A., Larque, A. B., Bomback, A. S., Morantes, L., Martínez-Chillarón, M., Ollé, J., Guillén, E., Xipell, M., Molina-Andújar, A., Rodríguez, D., Cuadrado, E., Cacho, J., Arana, C., Esforzado, N., Bastida, C., Poch, E., Diekman, F., … Blasco, M. (2024). Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases. Kidney Medicine, 6(6), 100823. https://doi.org/10.1016/j.xkme.2024.100823

Horn, K. W., Shah, S. S., Skoll, D., Carter, D., Freeman, N. S., & Husain, S. A. (2024). The Case | Proximal muscle weakness, hypertension, and electrolyte abnormalities. Kidney International, 105(4), 895–896. https://doi.org/10.1016/j.kint.2023.10.015

Ndife, B., Aldworth, C., Murphy, K. P., Nguyen, J., Pivneva, I., Edwards, M. L., Anderson, A., Signorovitch, J., & Canetta, P. (2024). WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT. Kidney International Reports, 9(4), S244. https://doi.org/10.1016/j.ekir.2024.02.501

Quintana-Gallardo, L., Bomback, A., Daina, E., Kanellis, J., Kavanagh, D., Pickering, M. C., Sunder-Plassmann, G., Walker, P., Wang, Z., Ahmad, Z., & Fakhouri, F. (2024). WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN). Kidney International Reports, 9(4), S138–S139. https://doi.org/10.1016/j.ekir.2024.02.286

Trimarchi, H., Barratt, J., Radhakrishnan, J., Rizk, D. V., Sorensen, B., Leiske, J., Khawaja, Z., Campbell, K., & Perkovic, V. (2024). WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY. Kidney International Reports, 9(4), S177. https://doi.org/10.1016/j.ekir.2024.02.362

Husain, S. A., Khanna, S., Yu, M., Adler, J. T., Cron, D. C., King, K. L., Schold, J. D., & Mohan, S. (2024). Cold Ischemia Time and Delayed Graft Function in Kidney Transplantation: A Paired Kidney Analysis. Transplantation. https://doi.org/10.1097/tp.0000000000005006

Ndife, B., Aldworth, C., Murphy, K. P., Nguyen, J., Pivneva, I., Edwards, M. L., Anderson, A., Signorovitch, J., & Canetta, P. (2024). WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT. Kidney International Reports, 9(4), S243. https://doi.org/10.1016/j.ekir.2024.02.499

Ma, B. M., Elefant, N., Tedesco, M., Bogyo, K., Vena, N., Murthy, S. K., Bheda, S. A., Yang, S., Tomar, N., Zhang, J. Y., Husain, S. A., Mohan, S., Kiryluk, K., Rasouly, H. M., & Gharavi, A. G. (2024). Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney International, 106(1), 115–125. https://doi.org/10.1016/j.kint.2024.02.021

Fujita, M., Gao, Z., Zeng, L., McCabe, C., White, C. C., Ng, B., Green, G. S., Rozenblatt-Rosen, O., Phillips, D., Amir-Zilberstein, L., Lee, H., Pearse, R. V., Khan, A., Vardarajan, B. N., Kiryluk, K., Ye, C. J., Klein, H.-U., Wang, G., Regev, A., … De Jager, P. L. (2024). Cell subtype-specific effects of genetic variation in the Alzheimer’s disease brain. Nature Genetics, 56(4), 605–614. https://doi.org/10.1038/s41588-024-01685-y

Schold, Jesse. D., Tambur, A. R., Mohan, S., & Kaplan, B. (2024). Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States. Clinical Journal of the American Society of Nephrology, 19(6), 767–777. https://doi.org/10.2215/cjn.0000000000000449

Stern, L., Johnson, R. J., Shakouri, P., Athavale, A., Padnick-Silver, L., LaMoreaux, B., Marder, B. A., & Mandayam, S. (2024). Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review. Gout, Urate, and Crystal Deposition Disease, 2(1), 77–85. https://doi.org/10.3390/gucdd2010008

DiFranza, L. T., Daniel, E., Serban, G., Thomas, S. M., Santoriello, D., Ratner, L. E., D’Agati, V. D., Vasilescu, E.-R., Husain, S. A., & Batal, I. (2024). Collapsing glomerulopathy is likely a major contributing factor for worse allograft survival in patients receiving kidney transplants from black donors. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1369225

Raina, R., Jothi, S., Haffner, D., Somers, M., Filler, G., Vasistha, P., Chakraborty, R., Shapiro, R., Randhawa, P. S., Parekh, R., Licht, C., Bunchman, T., Sethi, S., Mangat, G., Zaritsky, J., Schaefer, F., Warady, B., Bartosh, S., McCulloch, M., … Radhakrishnan, J. (2024). Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney International, 105(3), 450–463. https://doi.org/10.1016/j.kint.2023.10.017

Zonozi, R., Aqeel, F., Le, D., Cortazar, F. B., Thaker, J., Zabala Ramirez, M. J., Sattui Cortes, S. E., Attieh, R. M., Chung, M., Bulbin, D. H., Shaikh, A., Guaman, K., Ford, J., Diffie, C., Gewurz-Singer, O., Sauvage, G., Jeyabalan, A., Geara, A., Ayoub, I., … Geetha, D. (2024). Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Kidney International Reports, 9(6), 1783–1791. https://doi.org/10.1016/j.ekir.2024.03.022

Batal, I., Nasr, S. H., Dasari, S., Weins, A., Vena, N., Stokes, M. B., Kiryluk, K., & Appel, G. B. (2024). Pathologic-genomic correlation identified a novel variant in FN1 and established the diagnosis of recurrent fibronectin glomerulopathy in the kidney allograft. American Journal of Transplantation, 24(3), 498–502. https://doi.org/10.1016/j.ajt.2023.10.012

Hu, X., Xu, J., Wang, W., Liu, L., Jing, Y., Gao, C., Yu, X., Li, Y., Lin, L., Tong, J., Weng, Q., Pan, X., Zhang, W., Ren, H., Li, G., Kiryluk, K., Chen, N., & Xie, J. (2024). Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 19(5), 573–582. https://doi.org/10.2215/cjn.0000000000000422

Sabatello, M., Bakken, S., Chung, W. K., Cohn, E., Crew, K. D., Kiryluk, K., Kukafka, R., Weng, C., & Appelbaum, P. S. (2024). Return of polygenic risk scores in research: Stakeholders’ views on the eMERGE-IV study. Human Genetics and Genomics Advances, 5(2), 100281. https://doi.org/10.1016/j.xhgg.2024.100281

Lange, N. W., King, K., Husain, S. A., Salerno, D. M., Tsapepas, D. S., Hedvat, J., Yu, M., & Mohan, S. (2024). Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials. American Journal of Transplantation, 24(6), 1027–1034. https://doi.org/10.1016/j.ajt.2024.02.015

Gbadegesin, R., Martinelli, E., Gupta, Y., Friedman, D. J., Sampson, M. G., Pollak, M. R., & Sanna-Cherchi, S. (2024). APOL1 genotyping is incomplete without testing for the protective M1 modifier p.N264K variant. Glomerular Diseases. Portico. https://doi.org/10.1159/000537948

Schold, J. D., Conzen, K. D., Cooper, J., Arrigain, S., Lopez, R., Mohan, S., Husain, S. A., Huml, A. M., Kennealey, P. T., Kaplan, B., & Pomfret, E. A. (2024). Quantifying the Effect of Consent for High–Kidney Donor Profile Index Deceased Donor Transplants in the United States. Journal of the American Society of Nephrology, 35(5), 630–641. https://doi.org/10.1681/asn.0000000000000318

Tsapepas, D., Ramakrishnan, A., Salerno, D. M., Husain, S. A., King, K., & Mohan, S. (2024). Impact of peri-operative red blood cell transfusions for treatment of anemia on acute rejection in renal transplant recipients. Transfusion and Apheresis Science, 63(3), 103896. https://doi.org/10.1016/j.transci.2024.103896

Singh, N., Anand, P. M., Gupta, G., Sawinski, D., Fix, O., Adey, D., Akalin, E., Zayas, C., Dadhania, D., Doshi, M., Cibrik, D., Gupta, M., Parsons, R., Leca, N., Santos, R. D., Concepcion, B. P., Nishio Lucar, A. G., Ong, S., Sridhar, V. S., … Bloom, R. (2024). Should Transplant Nephrology Pursue Recognition from the Accreditation Council for Graduate Medical Education (ACGME)? Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000000000000441

Zanoni, F., Neugut, Y. D., Obayemi, J. E., Liu, L., Zhang, J. Y., Ratner, L. E., Cohen, D. J., Mohan, S., Gharavi, A. G., Keating, B., & Kiryluk, K. (2024). Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in 2 multiethnic urban cohorts. American Journal of Transplantation, 24(6), 1003–1015. https://doi.org/10.1016/j.ajt.2024.01.033

Nakatsugawa, A. C., & Sampogna, R. V. (2024). Postnatal Nephrogenesis in Preterm Infants: The Need to Safeguard Kidney Development After Birth. Kidney International Reports, 9(2), 201–202. https://doi.org/10.1016/j.ekir.2023.12.013

Duret, L. C., Hamidouche, T., Steers, N. J., Pons, C., Soubeiran, N., Buret, D., Gilson, E., Gharavi, A. G., D’Agati, V. D., & Shkreli, M. (2024). Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy. Kidney International, 105(5), 980–996. https://doi.org/10.1016/j.kint.2024.02.009

Nasr, S. H., Valeri, A. M., Said, S. M., Sethi, S., Nath, K. A., Lieske, J. C., & Bu, L. (2024). Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy. Mayo Clinic Proceedings, 99(4), 593–606. https://doi.org/10.1016/j.mayocp.2023.08.014

Arman, F., Kadosh, D., & Canetta, P. (2024). Sodium zirconium cyclosilicate mimicking enteric radiocontrast. Kidney International, 105(2), 394. https://doi.org/10.1016/j.kint.2023.08.015

Avasare, R. S., Clark, S., Spain, R. I., Wusirika, R., Rope, R., Gurley, S., Stanaway, M., Sekulic, M., Santoriello, D., Bomback, A. S., Canetta, P., Iyer, S. J., Kung, V., Charu, V., Troxell, M. L., Kudose, S., & Andeen, N. K. (2024). Characteristics and Outcomes of NELL1 Membranous Nephropathy in Lipoic Acid Users and Nonusers. Kidney International Reports, 9(5), 1379–1386. https://doi.org/10.1016/j.ekir.2024.02.1401

Sekulic, M., Batal, I., Kudose, S., Santoriello, D., Stokes, M. B., Jim, B., Marti, H.-P., Eikrem, Ø., Radhakrishnan, J., D’Agati, V. D., & Markowitz, G. S. (2024). Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis. Kidney International Reports, 9(2), 410–422. https://doi.org/10.1016/j.ekir.2023.10.033

Zhao, E., Bomback, M., Khan, A., Krishna Murthy, S., Solowiejczyk, D., Vora, N. L., Gilmore, K. L., Giordano, J. L., Wapner, R. J., Sanna‐Cherchi, S., Lyford, A., Jelin, A. C., Gharavi, A. G., & Hays, T. (2024). The expanded spectrum of human disease associated with GREB1L likely includes complex congenital heart disease. Prenatal Diagnosis, 44(3), 343–351. Portico. https://doi.org/10.1002/pd.6527